Analyzing Long-Term Follow-Up Results From MonumenTAL-1 in Multiple Myeloma
Written by
Cancer Network
Published
0
comments
0
min
Experts discussed talquetamab's unique mechanism and favorable patient outcomes in relapsed/refractory multiple myeloma.